共 50 条
- [21] Obesity and Glucagon-Like Peptide-1 Receptor Agonists JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (07): : 561 - 562
- [22] Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (02): : 113 - 114
- [23] Glucagon-Like Peptide-1 Receptor: A Novel Receptor in Platelets DIABETES, 2015, 64 : A528 - A528
- [24] Impact of glucagon-like peptide-1 on endothelial function DIABETES OBESITY & METABOLISM, 2009, 11 : 19 - 25
- [25] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
- [27] Glucagon-Like Peptide-1 and its Cardiovascular Effects Current Atherosclerosis Reports, 2012, 14 : 422 - 428
- [30] STRUCTURE/ACTIVITY CHARACTERIZATION OF GLUCAGON-LIKE PEPTIDE-1 EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 225 (03): : 1151 - 1156